Barr Laboratories

Drug Store News, August 18, 2003 by James Frederick

Barr Laboratories settled its patent litigation late last month with Ortho-McNeil Pharmaceutical and, as a result, will be permitted to introduce a generic version of the oral contraceptive Ortho Tri-Cyclen no later than Dec. 29.

Ortho Tri-Cyclen is an oral contraceptive that includes three different tablet combinations of norgestimate and ethinyl estradiol and is indicated for the prevention of pregnancy. The product, available in 28-tablet packaging, had annual sales of about $713 million for the 12 months ended May.

COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale